EUVIMEDEUVIMED entdecken
Open Access

EphA2-targeted alpha-particle theranostics for enhancing PDAC treatment

Ajay Kumar Sharma, Kuldeep Gupta, Akhilesh Mishra, Gabriela Lofland, Sophia Y Chen, Ian Marsh, Peyton T Fair, Robert F Hobbs, Todd M Armstrong, Elizabeth M Jaffee, Edward W Gabrielson, Lei Zheng und 1 weitere

Theranostics · 18.03.2025 · 15 (10) · 4229-4246

DOI: 10.7150/thno.106948 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, erschienen am 18.03.2025. Verfasst von Ajay Kumar Sharma und 12 weiteren Autor:innen. Beteiligte Einrichtung: The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA. Hauptthemen laut MEDLINE: Receptor, EphA2, Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal, Theranostic Nanomedicine. Die Arbeit wurde bisher 20-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, EphA2Pancreatic NeoplasmsCarcinoma, Pancreatic DuctalTheranostic NanomedicineAlpha ParticlesHumansAnimalsCell Line, TumorMicePositron-Emission TomographyXenograft Model Antitumor AssaysGallium RadioisotopesRadiopharmaceuticalsMice, NudePrecision Medicine

Stichwörter der Autor:innen

Alpha-particle therapyGallium-68ImagingPETPancreatic cancerPeptide radiopharmaceuticalsRadiotherapy

Substanzen

Receptor, EphA2EPHA2 protein, humanGallium RadioisotopesRadiopharmaceuticalsGallium-68

Autor:innen und Institutionen

  • The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.
  • Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center and the Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.
  • Department of Pathology and Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.
  • Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.
  • Division of Clinical Pharmacology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.

Förderung

  • NCI NIH HHS

Zitieren

APA

Sharma, A. K., Gupta, K., Mishra, A., Lofland, G., Chen, S. Y., Marsh, I., Fair, P. T., Hobbs, R. F., Armstrong, T. M., Jaffee, E. M., Gabrielson, E. W., Zheng, L., & Nimmagadda, S. (2025). EphA2-targeted alpha-particle theranostics for enhancing PDAC treatment. Theranostics, 15(10), 4229-4246. https://doi.org/10.7150/thno.106948

Vancouver

Sharma AK, Gupta K, Mishra A, Lofland G, Chen SY, Marsh I, et al. EphA2-targeted alpha-particle theranostics for enhancing PDAC treatment. Theranostics. 2025;15(10):4229-4246. doi:10.7150/thno.106948

BibTeX
@article{Sharma2025,
  author = {Sharma, Ajay Kumar and Gupta, Kuldeep and Mishra, Akhilesh and Lofland, Gabriela and Chen, Sophia Y and Marsh, Ian and Fair, Peyton T and Hobbs, Robert F and Armstrong, Todd M and Jaffee, Elizabeth M and Gabrielson, Edward W and Zheng, Lei and Nimmagadda, Sridhar},
  title = {EphA2-targeted alpha-particle theranostics for enhancing PDAC treatment},
  journal = {Theranostics},
  year = {2025},
  volume = {15},
  number = {10},
  pages = {4229--4246},
  doi = {10.7150/thno.106948}
}
Kostenlos starten →